Executives On The Move: Amicus Therapeutics, Perrigo and More
Executive Summary
Recent executive moves in the industry include C-suite changes at Amicus Therapeutics and Assembly Biosciences. Meanwhile, new directors were appointed at Torrent Pharmaceuticals and Perrigo, among others.
You may also be interested in...
Pipeline Watch: Six New Approvals And 20 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: Nine Approvals And Seven Phase III Trial Starts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Herantis Pharma, Cyclerion Therapeutics and More
Recent executive changes in the industry include C-suite changes at Herantis Pharma and MediGene. Meanwhile, new directors were appointed at Cyclerion Therapeutics and Allakos, among others.